Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944)/Experiment 6

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi, Victoria

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Vagina Vagina,vagina,Distal oviductal region,Distal portion of oviduct,Vaginae
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Urinary tract infection INFECTION, URINARY TRACT,TRACT, INFECTION OF URINARY,urinary tract infection,urinary tract infection (disease),Urinary tract infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Day 1 (pre-dose)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Follow-up (visit around Day 28 ± 3 days).
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
this represented the condition approximately one month post-treatment, after the cessation of gepotidacin in vaginal microbiome
Group 0 sample size Number of subjects in the control (unexposed) group
22
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.01
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi

Source: within results text under "changes in detected abundances in bacterial genera", paragraph 3, Figure 3

Description: Relative abundances of assigned bacterial taxa.

Abundance in Group 1: increased abundance in Follow-up (visit around Day 28 ± 3 days).

NCBI Quality ControlLinks
Bifidobacterium
Butyricicoccus
Eubacterium ventriosum
Fretibacterium
Lachnospira
Mitsuokella
Oscillibacter
Parvimonas
Pseudomonas
Ruminiclostridium
Selenomonas
Treponema
Leptotrichia
Bacteroides
Fusobacterium
Veillonella

Revision editor(s): Chinelsy, Folakunmi

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi

Source: within results text under "changes in detected abundances in bacterial genera", paragraph 3, Figure 3

Description: Relative abundances of assigned bacterial taxa.

Abundance in Group 1: decreased abundance in Follow-up (visit around Day 28 ± 3 days).

NCBI Quality ControlLinks
Acidaminococcus
Actinomyces
Alistipes
Alloprevotella
Capnocytophaga
Christensenellaceae
Corynebacterium
Eubacterium coprostanoligenes
Faecalibacterium
Fusicatenibacter
Gemella
Granulicatella
Lachnoanaerobaculum
Lachnospiraceae
Oribacterium
Oscillospiraceae
Parabacteroides
Peptoniphilus
Peptostreptococcus
Prevotella
Roseburia
Tyzzerella
[Ruminococcus] torques
metagenome
Fusobacterium

Revision editor(s): Chinelsy, Folakunmi